Dolcera to speak at the PharmaCI conference 2009 at NY
September 14th, 2009 — adminThe PharmaCI conference is scheduled to be held on 15th - 16th September 2009 at New York. Ed Rozenberg, one of the founders of Dolcera will present a talk on “Unlocking the hidden potential from the abandoned molecules. - A systematic CI driven approach!”
With the advancement of pharma industry there are two trends which we have witnessed that each company is focusing on a handful of therapeutic areas and exiting from other therapeutic areas resulting in “orphaned” and “abandoned” molecules. More so, many other companies are targeting smaller subpopulations in many therapeutic areas based on the latest scientific understanding.
Dolcera will unfold that how competitive intelligence can help to utilize the accumulated knowledge (clinical trials, toxicology analysis etc.) of the abandoned molecules to bring them to the market very quickly. The strategy will be a combination of scientific, market and patent intelligence to help unlock very valuable opportunities.
We sincerely hope that this presentation from us would help the research community from some of the world’s top pharma, biotech and health care companies such as Global Pharma Alliance, Zymogenetics, Pfizer, Boehinger Ingelheim, Roche Diagnostics to name a few.
We welcome all our blog readers to be part of this conference and contribute to the knowledge shared.
